中新网哈尔滨10月9日电 (记者 欧阳开宇)“以重大疾病作为攻关突破口，开发具有独立知识产权的中药新药。”黑龙江省中医研究院院长王学军说。

Beijing on October 9, Harbin (Reporter OuYangKaiYu)"With major disease as research breakthrough,Development with independent intellectual property rights of new drug of TCM."The doctor of traditional Chinese medicine research institute in heilongjiang province WangXueJun said.

　　国家中医药管理局调研采访组日前来到黑龙江中医研究院。记者在走访中发现，在国家基本药物政策收紧、新药品种上市审查更加严格的情况下，该院以耐药性病原菌感染、恶性肿瘤、心脑血管疾病等重大疾病作为攻关突破口，探索出中药研发新途径。

The state administration of traditional Chinese medicine research CaiFangZu has come to heilongjiang institute of traditional Chinese medicine.Reporters found that the visit,In the national essential medicine policy tightening/New drug varieties listed review more stringent conditions,The hospital infection with bacteria resistance/Malignant tumor/Disease of heart head blood-vessel, etc as major disease research breakthrough,Explore new ways of traditional Chinese medicine research and development.

　　随着越来越多的国际医药企业进入中国医药市场。国内医药界面临更为激烈的市场竞争，生存与发展已成为众多国内医药机构面临的重要课题，这其中，新药研发与创新就显得至关重要。

With more and more international pharmaceutical enterprise to enter the Chinese medicine market.Domestic pharmaceutical industry facing more fierce market competition,Survival and development has become the domestic medical institutions are facing many of the important topic,the,New medicine r&d and innovation will be crucial.

　　新药研发是一项系统工程。王学军说，该院自主研发的芩百清肺浓缩丸、复方青龙衣胶囊、血畅胶囊3个中药新药，中标了科技部组织的新中国成立以来投资最多、规模最大的“重大新药创制项目”，获得国家立项资助。

New drug research and development is a system engineering.WangXueJun said,The hospital of independent research and development Qin the clear lung concentrated pill/Compound tsing lung clothing capsule/Blood chang capsule three Chinese herbal medicine new medicine,Won the bid for the ministry of science and technology organization since the founding of the most investment/largest"Major new drug project initiative",Access to the national project funding.

　　近年来，中国官方不断加大对中医药发展的扶持力度，然而，中医药创新不够的问题依然存在，一些重大理论和关键技术尚未取得突破性进展。为此，《中医药事业发展“十二五”规划》明确提出，要进一步开展中医药基础理论、诊疗技术、疗效评价及标准等系统研究，推动中药新药和中医诊疗仪器、设备的研制与开发。

In recent years,China's official continuously strengthen the support for the development of traditional Chinese medicine,however,Traditional Chinese medicine innovation not enough problems still exist,Some important theories and key technologies have not obtained the breakthrough.therefore,[Traditional Chinese medicine career development"1025"planning]Clearly put forward,To further carry out the basic theory of traditional Chinese medicine/Diagnosis and treatment technology/Curative effect evaluation and standard etc system research,Promote Chinese herbal medicine new medicine and TCM diagnosis and treatment instrument/Equipment research and development.

　　从2008年开始，针对制药业出现的科技创新能力低、产品换代速度慢等情况，黑龙江中医研究院以中药多途径给药剂型创新开发平台作为主体，组建了产学研战略联盟，被科技部评为国家中药研发技术创新服务平台。

Begin from 2008,According to the pharmaceutical industry the creative ability of science and technology in low/Product generation speed slow, etc,Heilongjiang institute of traditional Chinese medicine of traditional Chinese medicine in many ways to drug dosage form innovation development platform as the main body,The combination of strategic alliance was established,By ministry of science and technology as national Chinese medicine research and development technology innovation service platform.

　　“我们的平台建设主要有中药新药开发、药物安全评价、科技合作、名牌产品二次开发技术服务，现在还开始对名老中医的经方验方进行收集、整理、研发，对中药剂型改进技术和全省药材资源的开发利用技术服务平台建设等。”王学军说，这些平台的建设不仅有利于发挥全院的中医药科研优势，而且有利于整合中医药的科研、技术和人才资源为企业服务，促进中药产业发展。

"Our platform construction are mainly the development of new drug of TCM/Drug safety evaluation/Scientific and technological cooperation/Famous brand product secondary development technical service,Now also start to old doctor of traditional Chinese medicine prescription of the party for the collection/finishing/r&d,The traditional Chinese medicine dosage form improvement techniques and the development and utilization of the medicinal resources technical service platform construction, etc."WangXueJun said,These platform construction is not only beneficial to play the partial Chinese medicine scientific research advantage,But also is beneficial to integration of traditional Chinese medicine research/Technology and human resources for enterprise services,To promote the development of traditional Chinese medicine industry.

　　随着中医养生热潮的兴起，该院也开始在新药开发过程中注重北药特色系列保健品的开发。

With the rise of medicine boom,The hospital also began in new drug development process in the north to pay attention to the development of medicine characteristics series health care products.

　　“我们以北药道地药材为原料，结合现代工艺，开发了寝安袋泡茶、豪饮含片、肠胃爽片、清风饮袋泡茶等10余种亚健康系列保健品，连续两年被黑龙江省政府列入百项工程的十项重点工程之一。”王学军说。

"Our genuine medicinal materials as raw material of medicine,Combined with modern technology,The development of bed Ann tea bag/Booze lozenge/Intestines and stomach great piece of/The wind drink tea bag, and other 10 kinds of subhealth series of health products,For two consecutive years in heilongjiang province by the government on the project one of ten key projects."WangXueJun said.

　　为鼓励科研和临床人员积极开展科研创新，2009年以来，研究院先后制订了多项政策措施，对科研课题的支持、科技成果奖励和资金匹配作出明确规定，对具有学术意义和应用价值的成果、论文或专著给予奖励，鼓励科研人员进行科技创新。

To encourage scientific research and clinical staff actively carry out scientific research innovation,Since 2009,Research institute has made a number of policy measures,To support scientific research subject/Science and technology achievement award and capital matching explicitly provided,With the academic significance and the application value of the results/Thesis or book reward,To encourage scientific research personnel for science and technology innovation.

　　提及科研转化，王学军说，该院从科研的选题、立项到新产品的试制均以市场为导向，多方寻求合作伙伴，形成了以中药研发为核心，利益共享、风险共担的中药研发体系，“缩短了成果转化周期，有效回避了风险”。(完)

Refer to research into,WangXueJun said,From the hospital scientific research subject/Project to new product development are market-oriented,Many seek cooperation partners,Formed a Chinese traditional medicine research and development as the core,Pooling of interest/Risk sharing system of traditional Chinese medicine research and development,"Shorten the achievement transformation period,Effectively avoid the risk".(finish)